New players in the field of antiplatelet and anticoagulant therapy in coronary heart disease - current therapeutic issues and hot topics

Alban, S. ( 2005) From Heparins to Factor Xa Inhibitors and Beyond. Eur J Clin Invest 35(Suppl 1): 12-20.

Alexander, J.H. ( 2009) The Current State of Antiplatelet Therapy in Acute Coronary Syndromes: The Data and the Real World. Cleve Clin J Med 76(Suppl 1): S16-23.

Anderson, J.L. , Adams, C.D. , Antman, E.M. , Bridges, C.R. , Califf, R.M. , Casey Jr, D.E. et al. (2007) Acc/Aha 2007 Guidelines for the Management of Patients with Unstable Angina/ Non-St-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients with Unstable Angina/Non-St-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 50: e1-e157.

Anderson, J.L. , Adams, C.D. , Antman, E.M. , Bridges, C.R. , Califf, R.M. , Casey Jr, D.E. et al. (2007) Acc/ Aha 2007 Guidelines for the Management of Patients with Unstable Angina/Non St-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients with Unstable Angina/Non St-Elevation Myocardial Infarction): Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation 116: e148-304.

Bliden, K.P. , Dichiara, J. , Tantry, U.S. , Bassi, A.K. , Chaganti, S.K. and Gurbel, P.A. ( 2007) Increased Risk in Patients with High Platelet Aggregation Receiving Chronic Clopidogrel Therapy Undergoing Percutaneous Coronary Intervention: Is the Current Antiplatelet Therapy Adequate? J Am Coll Cardiol 49: 657-666.

Bowry, A.D. , Brookhart, M.A. and Choudhry, N.K. ( 2008) Meta-Analysis of the Efficacy and Safety of Clopidogrel Plus Aspirin as Compared to Antiplatelet Monotherapy for the Prevention of Vascular Events. Am J Cardiol 101: 960-966.

Brandt, J.T. , Payne, C.D. , Wiviott, S.D. , Weerakkody, G. , Farid, N.A. , Small, D.S. et al. (2007) A Comparison of Prasugrel and Clopidogrel Loading Doses on Platelet Function: Magnitude of Platelet Inhibition Is Related to Active Metabolite Formation. Am Heart J 15366.e92-16.

Campbell, C.L. , Smyth, S. , Montalescot, G. and Steinhubl, S.R. ( 2007) Aspirin Dose for the Prevention of Cardiovascular Disease: A Systematic Review. Jama 297: 2018-2024.

Cohen, M. , Bhatt, D.L. , Alexander, J.H. , Montalescot, G. , Bode, C. , Henry, T. et al. (2007) Randomized, Double-Blind, Dose-Ranging Study of Otamixaban, a Novel, Parenteral, Short-Acting Direct Factor Xa Inhibitor, in Percutaneous Coronary Intervention: The Sepia-Pci Trial. Circulation 115: 2642-2651.

Connolly, S.J. , Ezekowitz, M.D. , Yusuf, S. , Eikelboom, J. , Oldgren, J. , Parekh, A. et al. (2009) Dabigatran versus Warfarin in Patients with Atrial Fibrillation . N Engl J Med 12: 1139-1151.

Cuisset, T. , Frere, C. , Quilici, J. , Poyet, R. , Gaborit, B. , Bali, L. et al. (2009) Comparison of Omeprazole and Pantoprazole Influence on a High 150-Mg Clopidogrel Maintenance Dose the Paca (Proton Pump Inhibitors and Clopidogrel Association) Prospective Randomized Study. J Am Coll Cardiol 54: 1149-1153.

Eshaghian, S. , Kaul, S. , Amin, S. , Shah, P.K. and Diamond, G.A. ( 2007) Role of Clopidogrel in Managing Atherothrombotic Cardiovascular Disease. Ann Intern Med 146: 434-441.

Fauler, J. ( 2009) Clinical Pharmacology of Antithrombotic Drugs in Coronary Artery Disease. Ther Adv Cardiovasc Dis, Ther Adv Cardiovasc Dis. Epub 2009 Sept 2 as doi: 10.1177/ 1753944709346517.

Jernberg, T. , Payne, C.D. , Winters, K.J. , Darstein, C. , Brandt, J.T. , Jakubowski, J.A. et al. (2006) Prasugrel Achieves Greater Inhibition of Platelet Aggregation and a Lower Rate of Non-Responders Compared with Clopidogrel in Aspirin-Treated Patients with Stable Coronary Artery Disease. Eur Heart J 27: 1166-1173.

Lewis Jr, H.D. , Davis, J.W. , Archibald, D.G. , Steinke, W.E. , Smitherman, T.C. , Doherty 3rd, J.E. , et al. (1983) Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable Angina. Results of a Veterans Administration Cooperative Study. N Engl J Med 309: 396-403.

Mega, J.L. , Braunwald, E. , Mohanavelu, S. , Burton, P. , Poulter, R. , Misselwitz, F. et al. (2009) Rivaroxaban Versus Placebo in Patients with Acute Coronary Syndromes (Atlas Acs-Timi 46): A Randomised, Double-Blind, Phase Ii Trial . Lancet 374: 29-38.

O’Donoghue, M.L. , Braunwald, E. , Antman, E.M. , Murphy, S.A. , Bates, E.R. , Rozenman, Y. et al. (2009) Pharmacodynamic Effect and Clinical Efficacy of Clopidogrel and Prasugrel with or without a Proton-Pump Inhibitor: An Analysis of Two Randomised Trials. Lancet, Lancet 374: 989-997. Epub 2009 Aug 31.

Rao, S.V. ( 2009) Strategies to Reduce Bleeding among Patients with Ischemic Heart Disease Treated with Antiplatelet Therapies. Am J Cardiol 104: 60C-63C.

Sabatine, M.S. , Antman, E.M. , Widimsky, P. , Ebrahim, I.O. , Kiss, R.G. , Saaiman, A. et al. (2009) Otamixaban for the Treatment of Patients with Non-St-Elevation Acute Coronary Syndromes (Sepia-Acs1 Timi 42): A Randomised, Double-Blind, Active-Controlled, Phase 2 Trial. Lancet 374: 787-795.

Sibbing, D. (2009) Impact of Concomitant Oral Anticoagulation with a Coumarine Derivate on the Antiplatelet Effects of Clopidogrel. European Society of Cardiology Meeting Abstract 5114.

Unger, E.F. ( 2009) Weighing Benefits and Risks-the Fda’s Review of Prasugrel. N Engl J Med 361: 942-945.

Wallentin, L. (2009) P2y(12) Inhibitors: Differences in Properties and Mechanisms of Action and Potential Consequences for Clinical Use. Eur Heart J 30: 1964-1977.

Wallentin, L. , Becker, R.C. , Budaj, A. , Cannon, C.P. , Emanuelsson, H. , Held, C. et al. (2009) Ticagrelor Versus Clopidogrel in Patients with Acute Coronary Syndromes. N Engl J Med 361: 1045-1057.

Wiviott, S.D. , Trenk, D. , Frelinger, A.L. , O’donoghue, M. , Neumann, F.J. , Michelson, A.D. et al. (2007) Prasugrel Compared with High Loading- and Maintenance-Dose Clopidogrel in Patients with Planned Percutaneous Coronary Intervention: The Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 Trial. Circulation 116: 2923-2932.